Literature DB >> 17768670

Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2.

Chih-Yun Lai1, Hsien-Ping Hu, Chwan-Chuen King, Wei-Kung Wang.   

Abstract

While virus-like particles (VLPs) containing subgenomic replicons, which can transduce replicons into target cells efficiently for studying viral replication and vectors of gene therapy and vaccine, have been established for several flaviviruses, none has been reported for the four serotypes of dengue virus, the causal agent of the most important arboviral diseases in this century. In this study, we successfully established a cell line stably expressing the precursor membrane/envelope (PrM/E) proteins of dengue virus type 2 (DENV2), which can package a DENV2 replicon with deletion of PrM/E genes and produce single-round infectious VLPs. Moreover, it can package a similar replicon of different serotype, dengue virus type 4, and produce infectious chimeric VLPs. To our knowledge, this study reports for the first time replicon-containing VLPs of dengue virus. Moreover, this convenient system has potential as a valuable tool to study encapsidation of dengue virus and to develop novel chimeric VLPs containing dengue virus replicon as vaccine in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17768670     DOI: 10.1007/s11373-007-9204-0

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  6 in total

1.  Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

Authors:  Camilo Ansarah-Sobrinho; Steevenson Nelson; Christiane A Jost; Stephen S Whitehead; Theodore C Pierson
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

2.  Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.

Authors:  Chi-Chen Yang; Yi-Chen Hsieh; Shiow-Ju Lee; Szu-Huei Wu; Ching-Len Liao; Chang-Huei Tsao; Yu-Sheng Chao; Jyh-Haur Chern; Chung-Pu Wu; Andrew Yueh
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

3.  Distinct expression of interferon-induced protein with tetratricopeptide repeats (IFIT) 1/2/3 and other antiviral genes between subsets of dendritic cells induced by dengue virus 2 infection.

Authors:  Jingshu Zhang; Daniel Man-Yuen Sze; Benjamin Yat-Ming Yung; Petrus Tang; Wei-June Chen; Kwok-Hung Chan; Polly Hang-Mei Leung
Journal:  Immunology       Date:  2016-08       Impact factor: 7.397

4.  Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II.

Authors:  Chih-Yun Lai; Wen-Yang Tsai; Su-Ru Lin; Chuan-Liang Kao; Hsien-Ping Hu; Chwan-Chuen King; Han-Chung Wu; Gwong-Jen Chang; Wei-Kung Wang
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

5.  Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes.

Authors:  Kimberly Mattia; Bridget A Puffer; Katherine L Williams; Ritela Gonzalez; Meredith Murray; Emily Sluzas; Dan Pagano; Sandya Ajith; Megan Bower; Eli Berdougo; Eva Harris; Benjamin J Doranz
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

6.  Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors.

Authors:  I-Jung Liu; Chuan-Liang Kao; Szu-Chia Hsieh; Ming-Tsair Wey; Lon-Sing Kan; Wei-Kung Wang
Journal:  Antiviral Res       Date:  2008-11-05       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.